semaglutide approved for mash FDA Approves Wegovy® as First Treatment GI and Hepatology News -
Description
Here's the honest breakdown what's been approved, when prices will actually drop, and why Wegovy patients won't see savings yet.

mL = milliliter

Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection

Gentle on the stomach

Get personalized nutrition & lifestyle consultations today!
Optimize GLP-1 coverage with HealthCheck360scalable, cost-effective solutions that boost care and employee satisfaction.
